Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part II

Kristi J. Smock; Robert C. Gosselin

doi:10.1055/s-0043-1769482

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2023; 49(06): 569-570
DOI: 10.1055/s-0043-1769482

Preface

Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part II

Kristi J. Smock

¹Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, Utah

,

Robert C. Gosselin

²University of California, Davis Health System, Hemostasis and Thrombosis Center, Sacramento, California

› Author Affiliations

Abstract

Full Text

References

References
1 Adcock DM, Moore GW, Montalvão SDL, Kershaw G, Gosselin RC. Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art. Semin Thromb Hemost 2023; 49 (06) 571-579
2 Saadalla A, Seheult J, Pruthi RK, Chen D. Von Willebrand factor multimer analysis and classification: a comprehensive review and updates. Semin Thromb Hemost 2023; 49 (06) 580-591
3 Nogami K. Clot waveform analysis for monitoring hemostasis. Semin Thromb Hemost 2023; 49 (06) 592-599
4 Larsen JB, Hvas AM, Hojbjerg JA. Platelet function testing: update and future directions. Semin Thromb Hemost 2023; 49 (06) 600-608
5 Bowyer AE, Gosselin RC. Factor VIII and factor IX activity measurements for haemophilia diagnosis and related treatments. Semin Thromb Hemost 2023; 49 (06) 609-620
6 Warkentin TE, Greinacher A. Laboratory testing for HIT and VITT antibodies: a narrative review. Semin Thromb Hemost 2023; 49 (06) 621-633
7 Gardiner C, Echenagucia M, Gosselin RC. The future of laboratory developed tests in hemostasis laboratories. Semin Thromb Hemost 2023; 49 (06) 634-640
8 Marlar RA. Laboratory evaluation of antithrombin, protein C and protein S. Semin Thromb Hemost 2023; 49 (06) 641-650
9 Van Cott EM, Orlando C, Moore GW, Cooper PC, Meijer P, Marlar R. Subcommittee on Plasma Coagulation Inhibitors. Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH. J Thromb Haemost 2020; 18 (01) 17-22
10 Cooper PC, Pavlova A, Moore GW, Hickey KP, Marlar RA. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH. J Thromb Haemost 2020; 18 (02) 271-277
11 Marlar RA, Gausman JN, Tsuda H, Rollins-Raval MA, Brinkman HJM. Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH. J Thromb Haemost 2021; 19 (01) 68-74
12 Pruthi RK, Cheng D. The use of bypassing treatment strategies in hemophilia and their effect on laboratory testing. Semin Thromb Hemost 2023; 49 (06) 651-660